Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation;Unabhängige Prädiktoren für Mortalität bei IABP-unterstützter primärer Koronarintervention im akuten Myokardinfarkt mit kardiogenem Schock

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 111, Issue 8, 2016, Pages 715-722

  Schwarz, B ^a   Abdel Wahab, M ^a   Robinson, D R ^b   Richardt, G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Cardiogenic shock; Intra aortic balloon; Myocardial infarction; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPINEPHRINE; HEPARIN; NORADRENALIN;

ACUTE HEART INFARCTION; AGED; AORTA BALLOON; ARTICLE; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; COUNTERPULSATION; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; HEART INFARCTION; HOSPITAL MORTALITY; INTRAAORTIC BALLOON PUMP; MORTALITY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84947935858     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-015-0118-8     Document Type: Article

References (24)

1. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A (2010) Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 31:1828–1835
2. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH, for the SHOCK investigators (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625–634
3. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K, for the IABP-SHOCK II Trial Investigators (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296
4. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G, on behalf of the Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. doi:10.1016/S0140-6736(13)61783-3
5. Perera D, Lumley M, Pijls N, Patel MR (2013) Intra-aortic balloon pump trials: questions, answers, and unresolved issues. Circ Cardiovasc Interv 6:317–321
6. Kellner P, Prondzinsky R, Pallmann L, Siegmann S, Unverzagt S, Lemm H, Dietz S, Soukup J, Werdan K, Buerke M (2013) Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II. Med Klin Intensivmed Notfmed 108:666–674
7. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351
8. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110:e82–e292
9. van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24:28–66
10. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS, Investigators TRIUMPH (2009) Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 158:680–687
11. Cheng JM, Valk SD, den Uil CA, van der Ent M, Lagrand WK, van de Sande M, van Domburg RT, Simoons ML (2009) Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol 104:327–332
12. Geppert A, Doringer A, Delle-Karth G, Zorn G, Heinz G, Huber K (2006) Plasma concentration of interleukin-6, organ failure, vasopressor support and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 34:2035–2042
13. Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R (2002) Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 106:I-203–I-206
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
15. Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) A simplified acute physiology score for ICU patients. Crit Care Med 12:975–977
16. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M (2010) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP Shock Trail for attenuation of multiorgan dysfunction syndrome. Crit Care Med 38:152–160
17. Abdel-Wahab M, Schwarz B, Mostafa A, Toelg R, Richardt G (2011) Is the Syntax score a predictor of early outcome in patients with cardiogenic shock complicating acute myocardial infarction? EuroIntervention 7(Suppl M). (Abstract)
18. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468
19. Unverzagt S, Buerke M, de Waha A, Haerting J, Prietzner D, Seyfarth M, Thiele H, Werdan K, Zeymer U, Prondzinsky R (2015) Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. doi:10.1002/14651858
20. Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM (2011) Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 306:1329–1337
21. Van Nunen LX, van’t Veer M, Schampaert S, Rutten MC, van de Vosse FN, Patel MR, Pijls NH (2015) Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy. EuroIntervention 11:286–292
22. Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S, BCIS-1 Investigators (2013) Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 127:207–212
23. Abdel-Wahab M, Saad M, Kynast J, Geist V, Sherif MA, Richardt G, Toelg R (2010) Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 105:967–971
24. Cheng JM, van Leeuwen MA, de Boer SP, Wai MC, den Uil CA, Jewbali LS, van Geuns RJ, Kardys I, van Domburg RT, Boersma E, Zijlstra F, Akkerhuis KM (2013) Impact of intra-aortic balloon pump support initiated before versus after primary percutaneous coronary intervention in patients with cardiogenic shock from acute myocardial infarction. Int J Cardiol 168:3758–3763